On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q4 2023 earnings per share (EPS) of -$0.21, up 59.62% year over year. Total Acasti Pharma earnings for the quarter were -$2.39 million. In the same quarter last year, Acasti Pharma's earnings per share (EPS) was -$0.52.
As of Q1 2024, Acasti Pharma's earnings has grown year over year. Acasti Pharma's earnings in the past year totalled -$38.77 million.
What was ACST's revenue last quarter?
On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Acasti Pharma's revenue was $0.00.
What was ACST's revenue growth in the past year?
As of Q1 2024, Acasti Pharma's revenue has grown null year over year. Acasti Pharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.